Induction of effective antitumor immune responses in a mouse bladder tumor model by using DNA of an α antigen from mycobacteria
- 1 July 2001
- journal article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 8 (7) , 483-490
- https://doi.org/10.1038/sj.cgt.7700330
Abstract
Cancer Gene Therapy is the essential gene therapy resource for cancer researchers and clinicians, keeping readers up to date with the latest developments in gene therapy for cancer.Keywords
This publication has 39 references indexed in Scilit:
- Gene Therapy for Head and Neck CancerThe Laryngoscope, 2000
- Cytotoxic T lymphocyte response against non-immunoselected tumor antigens predicts the outcome of gene therapy with IL-12-transduced tumor cell vaccineGene Therapy, 1999
- Genetically modified tumour vaccines – where we are todayCancer Treatment Reviews, 1999
- Induction of Cytotoxic T–Cell Response Against Hepatitis C Virus Structural Antigens Using A Defective Recombinant AdenovirusHepatology, 1997
- Tumor cells cotransfected with interleukin‐7 and B7.1 genes induce CD25 and CD28 on tumor‐infiltrating T lymphocytes and are strong vaccinesEuropean Journal of Immunology, 1995
- The Biochemistry and Cell Biology of Antigen Processing and PresentationAnnual Review of Immunology, 1993
- Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma CellsScience, 1993
- Induction of anti-allo-class I H-2 tolerance by inactivation of CD8+ helper T cells, and reversal of tolerance through introduction of third-party helper T cells.The Journal of Experimental Medicine, 1990
- Antigen Recognition by Class I-Restricted T LymphocytesAnnual Review of Immunology, 1989
- Strain variation of lymphokine production and specific antibody secretion in mice infected with Mycobacterium lepraemuriumCellular Immunology, 1985